A New Era in Urticaria Treatment
All Things Urticaria – Learning about urticaria with Prof. Dr. Torsten ZuberbierShow Notes
In this episode of “All Things Urticaria” — a podcast from UCARE, the Global Allergy and Asthma Excellence Network — Prof. Torsten Zuberbier and Prof. Ana Giménez-Arnau discuss the newly released international urticaria guidelines. Developed with contributions from more than 100 societies and hundreds of experts worldwide, these guidelines represent a major step forward in the management of chronic spontaneous urticaria (CSU).
They discuss: 🔹 What makes the new urticaria guidelines more flexible than previous versions? 🔹 How has the treatment algorithm evolved beyond antihistamines and omalizumab? 🔹 What role do new therapies like remibrutinib and dupilumab play? 🔹 How can physicians choose the right treatment based on patient characteristics and comorbidities? 🔹 Why is early treatment escalation important for achieving disease control? 🔹 What does “assess and act” mean in daily clinical practice?
The episode highlights a shift toward individualized treatment decisions, shared decision-making with patients, and the integration of new therapeutic options. With a stronger focus on flexibility and real-world applicability, the new guidelines aim to improve outcomes for urticaria patients worldwide.
Key Learnings from the Episode: The new urticaria guidelines are more flexible than previous versions. Treatment decisions can now be individualized based on patient needs. New therapies such as remibrutinib and dupilumab expand treatment options. Omalizumab remains an important and well-established therapy. Early escalation of treatment is key when antihistamines fail. Combination therapies are now possible in certain cases. Comorbidities should guide treatment choice. Patient-reported outcomes are essential for disease management. Tools like the CRUSE app support monitoring and decision-making. “Assess and act” is a central principle in modern urticaria care.
Chapters: 00:00 Introduction to New Guidelines on Urticaria 03:35 Flexibility in Treatment Options 06:21 Understanding Non-Response and Treatment Decisions 09:08 Choosing the Right Treatment for Urticaria 12:00 Patient-Centered Care and Communication 14:37 Conclusion and Future Directions
Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.
Feedback form: ATU: https://forms.office.com/e/m6a2uEdsUH
More from All Things Urticaria – Learning about urticaria with Prof. Dr. Torsten Zuberbier
In this episode of the UCARE Global Allergy and Asthma Excellence Network podcast on Urticaria, Prof. Torsten Zuberbier speaks with Prof. Angelo Valerio Marzano from Milan about urticarial vasculitis and its challenging differential diagnoses. They explore how clinicians can distinguish urticarial vasculitis from chronic urticaria and other dermatological or systemic conditions and discuss practical approaches to diagnosis and treatment.
In this episode of the Global Allergy and Asthma Excellence Network UCARE Podcast on Urticaria, Prof. Torsten Zuberbier speaks with Prof. Marta Ferrer from Spain about an important question: Is chronic spontaneous urticaria (CSU) only a skin disease, or is it a systemic inflammatory condition? Together, they discuss emerging evidence showing that urticaria affects far more than the skin and how this should influence patient management.
In this episode of the UCARE Global Allergy and Asthma Excellence Network (Global Allergy and Asthma Excellence Network) podcast on Urticaria, Prof. Torsten Zuberbier speaks with Prof. Akio Tanaka from Hiroshima University, Japan, about an important question many patients ask: how long will chronic urticaria last, and can treatment influence the course of the disease? They discuss disease modification, symptom control, and future research directions in urticaria management.
In this episode of the UCARE GA²LEN (Global Allergy and Asthma Excellence Network) podcast on Urticaria, Prof. Torsten Zuberbier and Prof. Hermenio Lima discuss the growing role of artificial intelligence (AI) in medicine and how it may influence urticaria care, research, and patient management in the future.
In this episode of the UCARE GA²LEN (Global Allergy and Asthma Excellence Network) podcast on Urticaria, Prof. Torsten Zuberbier and Prof. Maia Gotua discuss the role of infections in acute and chronic urticaria. They explore how infections can trigger, mimic, or worsen symptoms—and why careful clinical evaluation is key.